Search Tag: Investigational New Drug
2021 24 Nov
Sedana Medical AB (publ) has announces that the company has submitted an Investigational New Drug (IND) application to the US Food and Drug Administration (FDA), with the aim to commence its phase III pivotal clinical trials with its Sedaconda products in the United States. Sedana Medical is aiming for a combination registration of the medical...Read more